These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33234127)

  • 1. Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients.
    Castagna L; Busca A; Bramanti S; Raiola Anna M; Malagola M; Ciceri F; Arcese W; Vallisa D; Patriarca F; Specchia G; Raimondi R; Devillier R; Furst S; Giordano L; Sarina B; Mariotti J; Olivieri A; Bouabdallah R; Carlo-Stella C; Rambaldi A; Santoro A; Corradini P; Bacigalupo A; Bonifazi F; Blaise D
    BMC Cancer; 2020 Nov; 20(1):1140. PubMed ID: 33234127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.
    Mariotti J; Devillier R; Bramanti S; Sarina B; Furst S; Granata A; Faucher C; Harbi S; Morabito L; Chabannon C; Carlo-Stella C; Bouabdallah R; Santoro A; Blaise D; Castagna L
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):627-632. PubMed ID: 29197681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.
    Ahmed S; Kanakry JA; Ahn KW; Litovich C; Abdel-Azim H; Aljurf M; Bacher VU; Bejanyan N; Cohen JB; Farooq U; Fuchs EJ; Bolaños-Meade J; Ghosh N; Herrera AF; Hossain NM; Inwards D; Kanate AS; Martino R; Munshi PN; Murthy H; Mussetti A; Nieto Y; Perales MA; Romee R; Savani BN; Seo S; Wirk B; Yared JA; Sureda A; Fenske TS; Hamadani M
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1859-1868. PubMed ID: 31132455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor KIR2DS1-Mediated Decreased Relapse and Improved Survival Depending on Remission Status at HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
    Ido K; Koh H; Hirose A; Okamura H; Koh S; Nanno S; Nishimoto M; Nakamae M; Nakashima Y; Nakane T; Hino M; Nakamae H
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):723-733. PubMed ID: 31899360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.
    Ghosh N; Karmali R; Rocha V; Ahn KW; DiGilio A; Hari PN; Bachanova V; Bacher U; Dahi P; de Lima M; D'Souza A; Fenske TS; Ganguly S; Kharfan-Dabaja MA; Prestidge TD; Savani BN; Smith SM; Sureda AM; Waller EK; Jaglowski S; Herrera AF; Armand P; Salit RB; Wagner-Johnston ND; Fuchs E; Bolaños-Meade J; Hamadani M
    J Clin Oncol; 2016 Sep; 34(26):3141-9. PubMed ID: 27269951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
    Burroughs LM; O'Donnell PV; Sandmaier BM; Storer BE; Luznik L; Symons HJ; Jones RJ; Ambinder RF; Maris MB; Blume KG; Niederwieser DW; Bruno B; Maziarz RT; Pulsipher MA; Petersen FB; Storb R; Fuchs EJ; Maloney DG
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1279-87. PubMed ID: 18940683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT.
    Battipaglia G; Boumendil A; Labopin M; Ciceri F; Tischer J; Stelljes M; Ehninger G; Beelen D; Finke J; Van Lint MT; Eder M; Afanasyev B; Fanin R; Mohty M; Ruggeri A; Nagler A
    Bone Marrow Transplant; 2019 Sep; 54(9):1499-1510. PubMed ID: 30718798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status.
    Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
    Ann Hematol; 2020 Dec; 99(12):2911-2925. PubMed ID: 33000361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Martínez C; Gayoso J; Canals C; Finel H; Peggs K; Dominietto A; Castagna L; Afanasyev B; Robinson S; Blaise D; Corradini P; Itälä-Remes M; Bermúdez A; Forcade E; Russo D; Potter M; McQuaker G; Yakoub-Agha I; Scheid C; Bloor A; Montoto S; Dreger P; Sureda A;
    J Clin Oncol; 2017 Oct; 35(30):3425-3432. PubMed ID: 28846465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
    Gorin NC; Labopin M; Blaise D; de Groot M; Socié G; Bourhis JH; Ciceri F; Polge E; Nagler A; Mohty M
    Cancer; 2020 Mar; 126(5):1004-1015. PubMed ID: 31774557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy.
    Gauthier J; Castagna L; Garnier F; Guillaume T; Socié G; Maury S; Maillard N; Tabrizi R; Marchand T; Malfuson J; Gac A; Gyan E; Mercier M; Béguin Y; Delage J; Turlure P; Marçais A; Nguyen S; Dulery R; Bay J; Huynh A; Daguindau E; Cornillon J; Régny C; Michallet M; Peffault de Latour R; Yakoub-Agha I; Blaise D
    Bone Marrow Transplant; 2017 May; 52(5):689-696. PubMed ID: 28067872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
    Gauthier J; Poiré X; Gac AC; Leclerc M; Guillaume T; Chalandon Y; Nguyen S; Forcade E; Régny C; Bay JO; Bazarbachi A; Rohrlich PS; Huynh A; Farhi J; Marchand T; Malfuson JV; Pilorge S; Labussière-Wallet H; Renard C; Fornecker LM; Detrait M; Duléry R; Delage J; Ménard AL; Charbonnier A; Nelken B; Jubert C; Suarez F; de la Tour RP; Beguin Y; Schoemans H; Blaise D; Yakoub-Agha I
    Bone Marrow Transplant; 2018 Apr; 53(4):400-409. PubMed ID: 29330405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Leukocyte Antigen-Haploidentical Transplantation for Relapsed/Refractory Hodgkin Lymphoma: A Multicenter Analysis.
    Lacerda MP; Arrais Rodrigues C; Pereira AD; Novis Y; Fonseca M; Silva RL; Macedo MCMA; Hamerschlak N; Esteves I; Schmidt Filho J; Nascimento MM; Rocha V
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):705-707. PubMed ID: 28108270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study.
    Bazarbachi A; Boumendil A; Finel H; Castagna L; Dominietto A; Blaise D; Diez-Martin JL; Tischer J; Gülbas Z; Wallet HL; Corral LL; Mohty M; Koc Y; Yakoub-Agha I; Schmid C; El Cheikh J; Arat M; Forcade E; Dreger P; Rocha V; García GG; Chalandon Y; Ferra C; Orvain C; Robinson S; Montoto S; Sureda A
    Br J Haematol; 2020 Mar; 188(5):745-756. PubMed ID: 31498883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.
    Castagna L; Bramanti S; Devillier R; Sarina B; Crocchiolo R; Furst S; El-Cheikh J; Granata A; Faucher C; Harbi S; Morabito L; Mariotti J; Puvinathan S; Weiller PJ; Chabannon C; Mokart D; Carlo-Stella C; Bouabdallah R; Santoro A; Blaise D
    Bone Marrow Transplant; 2017 May; 52(5):683-688. PubMed ID: 28092347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability.
    Sarina B; Castagna L; Farina L; Patriarca F; Benedetti F; Carella AM; Falda M; Guidi S; Ciceri F; Bonini A; Ferrari S; Malagola M; Morello E; Milone G; Bruno B; Mordini N; Viviani S; Levis A; Giordano L; Santoro A; Corradini P;
    Blood; 2010 May; 115(18):3671-7. PubMed ID: 20220116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Salvatore D; Labopin M; Ruggeri A; Battipaglia G; Ghavamzadeh A; Ciceri F; Blaise D; Arcese W; Sociè G; Bourhis JH; Van Lint MT; Bruno B; Huynh A; Santarone S; Deconinck E; Mohty M; Nagler A
    Haematologica; 2018 Aug; 103(8):1317-1328. PubMed ID: 29748438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
    Santoro N; Ruggeri A; Labopin M; Bacigalupo A; Ciceri F; Gülbaş Z; Huang H; Afanasyev B; Arcese W; Wu D; Koc Y; Tischer J; Santarone S; Giebel S; Mohty M; Nagler A
    J Hematol Oncol; 2017 May; 10(1):113. PubMed ID: 28558762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.
    Rashidi A; Hamadani M; Zhang MJ; Wang HL; Abdel-Azim H; Aljurf M; Assal A; Bajel A; Bashey A; Battiwalla M; Beitinjaneh AM; Bejanyan N; Bhatt VR; Bolaños-Meade J; Byrne M; Cahn JY; Cairo M; Ciurea S; Copelan E; Cutler C; Daly A; Diaz MA; Farhadfar N; Gale RP; Ganguly S; Grunwald MR; Hahn T; Hashmi S; Hildebrandt GC; Holland HK; Hossain N; Kanakry CG; Kharfan-Dabaja MA; Khera N; Koc Y; Lazarus HM; Lee JW; Maertens J; Martino R; McGuirk J; Munker R; Murthy HS; Nakamura R; Nathan S; Nishihori T; Palmisiano N; Patel S; Pidala J; Olin R; Olsson RF; Oran B; Ringden O; Rizzieri D; Rowe J; Savoie ML; Schultz KR; Seo S; Shaffer BC; Singh A; Solh M; Stockerl-Goldstein K; Verdonck LF; Wagner J; Waller EK; De Lima M; Sandmaier BM; Litzow M; Weisdorf D; Romee R; Saber W
    Blood Adv; 2019 Jun; 3(12):1826-1836. PubMed ID: 31201170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma.
    Nakaya Y; Nakamae H; Nishikubo M; Kondo E; Fukuda T; Hiramoto N; Mori Y; Nagafuji K; Eto T; Onishi Y; Uchida N; Ishikawa J; Matsuoka KI; Yui S; Takase K; Kawakita T; Kanda J; Ichinohe T; Atsuta Y; Kako S
    Bone Marrow Transplant; 2024 May; 59(5):630-636. PubMed ID: 38355911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.